Alimta (Pemetrexed) and Cisplatin Treatment as Neoadjuvant Therapy in Non Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 10 May 2011
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 May 2011 New source identified and integrated (European Clinical Trials Database).
- 10 May 2011 Planned end date changed from 1 Aug 2010 to 21 Sep 2010 according to European Clinical Trials Database.
- 09 Jun 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.